Bone Biologics (BBLG) Operating Expenses (2010 - 2025)
Bone Biologics (BBLG) reported Operating Expenses of $733105.0 for Q4 2025, down 52.85% year-over-year from $1.6 million in Q4 2024, and up 2.49% quarter-over-quarter from $715274.0 in Q3 2025.
Bone Biologics (BBLG) Operating Expenses (2010 - 2025) Analysis & Trends
Bone Biologics (BBLG) has 16 years of Operating Expenses data on file, last reported at $733105.0 in Q4 2025.
- Operating Expenses for Q4 2025 came in at $733105.0, down 52.85% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.2 million (down 23.33% YoY), and the FY2025 annual result was $3.2 million, down 23.33% from the prior year.
- Operating Expenses advanced to $733105.0 in Q4 2025 per BBLG's latest filing, from $715274.0 in the prior quarter.
- Over five years, Operating Expenses peaked at $3.1 million in Q1 2023 and troughed at $180924.0 in Q1 2021.
- A 5-year average of $1.1 million and a median of $856600.5 in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses soared 547.74% in 2023, then plunged 73.37% in 2024.
- A 5-year view of Operating Expenses shows it stood at $460482.0 in 2021, then soared by 179.51% to $1.3 million in 2022, then fell by 9.87% to $1.2 million in 2023, then jumped by 34.05% to $1.6 million in 2024, then sank by 52.85% to $733105.0 in 2025.
- Business Quant data shows BBLG's Operating Expenses at $733105.0 in Q4 2025, $715274.0 in Q3 2025, and $748075.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 15.76 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -67.40 Mn |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - | 733,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 733,105.00 |
| Sep 30, 2025 | 715,274.00 |
| Jun 30, 2025 | 748,075.00 |
| Mar 31, 2025 | 1.04 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Sep 30, 2024 | 951,021.00 |
| Jun 30, 2024 | 809,665.00 |
| Mar 31, 2024 | 903,536.00 |
| Dec 31, 2023 | 1.16 Mn |
| Sep 30, 2023 | 2.08 Mn |
| Jun 30, 2023 | 3.04 Mn |
| Mar 31, 2023 | 3.15 Mn |
| Dec 31, 2022 | 1.29 Mn |
| Sep 30, 2022 | 1.22 Mn |
| Jun 30, 2022 | 469,304.00 |
| Mar 31, 2022 | 689,499.00 |
| Dec 31, 2021 | 460,482.00 |
| Sep 30, 2021 | 229,789.00 |
| Jun 30, 2021 | 231,881.00 |
| Mar 31, 2021 | 180,924.00 |